EZH2 inhibition by itself does not reactivate the FMR1 gene in FXS cells; however, EZH2 inhibitors are very effective at preventing the re-silencing of reactivated alleles after 5-aza-dC is withdrawn [48]. The gene discussed is FMR1; the disease is fragile X syndrome.